Paper published in a journal (Scientific congresses and symposiums)
#P191 - Long-term follow-up (FU) of health-related quality of life (HRQoL) of patients (pts) with melanoma treated with adjuvant nivolumab (NIVO) in real-world (RW) setting
Rogiers, Anne; Willemot, Laurence; Van Campenhout, Hilde et al.
2026 • In Pigment Cell and Melanoma Research, 39 (1), p. 70074
Peer Reviewed verified by ORBi
 

Files


Full Text
P191.pdf
Author postprint (563.05 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Rogiers, Anne;  CHU Brugmann
Willemot, Laurence;  BMS - Bristol-Myers Squibb
Van Campenhout, Hilde;  BMS - Bristol-Myers Squibb
Jacobs, Céline;  UZ Gent - Ghent University Hospital
Blockx, Nathalie;  ZNA Middelheim
Rorive, Andrée ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
Neyns, Bart;  Universitair Ziekenhuis Brussel
Language :
English
Title :
#P191 - Long-term follow-up (FU) of health-related quality of life (HRQoL) of patients (pts) with melanoma treated with adjuvant nivolumab (NIVO) in real-world (RW) setting
Publication date :
January 2026
Event name :
Society for Melanoma Research 22nd International Congress
Event place :
Amsterdam, Netherlands
Event date :
25-28 October
Journal title :
Pigment Cell and Melanoma Research
ISSN :
1755-1471
eISSN :
1755-148X
Publisher :
Wiley
Volume :
39
Issue :
1
Pages :
e70074
Peer review/Selection committee :
Peer Reviewed verified by ORBi
Available on ORBi :
since 27 February 2026

Statistics


Number of views
204 (0 by ULiège)
Number of downloads
102 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenAlex citations
 
1

Bibliography


Similar publications



Contact ORBi